GlassScriptPhysician profile
Patrick Chihpin Hsu
NPI 1962405027
$2,414.50
in general payments reported to CMS, 2019-2025
20 companies · $83.78 in 2025
The $83.78 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $102 · 2021: $492 · 2022: $692 · 2023: $344 · 2024: $176 · 2025: $83.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.24 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $402.79 | 2021-2022 | |
| Cvrx, INC. | $360.12 | 2023-2024 | Barostim Neo System |
| Amarin Pharma, INC. | $215.61 | 2019 | |
| Impulse Dynamics (USA) INC. | $191.25 | 2022-2023 | Optimizer |
| Medtronic, INC. | $166.56 | 2021 | |
| Portola Pharmaceuticals, LLC | $135.41 | 2019 | |
| Abbott Laboratories | $125.39 | 2023 | Mitraclip |
| Boston Scientific Corporation | $125.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.77 | 2019-2025 | Eliquis |
| Philips North America LLC | $118.19 | 2022 | |
| Biotronik INC. | $108.55 | 2019-2022 | |
| Novo Nordisk INC | $102.28 | 2022 | |
| Medtronic Vascular, INC. | $101.97 | 2020 | |
| Alnylam Pharmaceuticals INC. | $36.68 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $28.49 | 2019-2023 | Xarelto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.94 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.55 | 2025 | |
| Amgen INC. | $13.87 | 2025 | Repatha |
| Allergan, INC. | $12.84 | 2019 | |
| Cardinal Health 200 LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.